日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients

更正：巴瑞替尼治疗类风湿性关节炎的比较疗效、停药时间和患者报告结局：来自欧洲患者的多国前瞻性观察性 RA-BE-REAL 研究的 2 年数据

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-025-00799-x
Alten, Rieke; Burmester, Gerd R; Matucci-Cerinic, Marco; Salmon, Jean-Hugues; Östör, Andrew; Ng, Khai Jing; Gerwien, Jens; Zaremba-Pechmann, Liliana; Brnabic, Alan J M; Fautrel, Bruno
关节炎
发表日期：2026
文献求助 收藏

The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis

RA-BE-REAL 多国前瞻性观察性研究：接受巴瑞替尼、靶向合成或生物制剂疾病修饰疗法治疗的类风湿关节炎患者的6个月中期分析

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-022-00500-6
Alten, Rieke; Burmester, Gerd R; Matucci-Cerinic, Marco; Salmon, Jean-Hugues; Lopez-Romero, Pedro; Fakhouri, Walid; de la Torre, Inmaculada; Zaremba-Pechmann, Liliana; Holzkämper, Thorsten; Fautrel, Bruno
关节炎
发表日期：2023
文献求助 收藏

Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients

巴瑞替尼治疗类风湿性关节炎的比较疗效、停药时间和患者报告结局：来自欧洲患者的多国前瞻性观察性 RA-BE-REAL 研究的 2 年数据

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-023-00597-3
Alten, Rieke; Burmester, Gerd R; Matucci-Cerinic, Marco; Salmon, Jean-Hugues; Östör, Andrew; Ng, Khai Jing; Gerwien, Jens; Zaremba-Pechmann, Liliana; Brnabic, Alan J M; Fautrel, Bruno
关节炎
发表日期：2023
文献求助 收藏

Global management of patients with knee osteoarthritis begins with quality of life assessment: a systematic review

膝骨关节炎患者的全球管理始于生活质量评估：一项系统评价

期刊:BMC Musculoskeletal Disorders
影响因子:2.4
doi:10.1186/s12891-019-2895-3
Vitaloni, Marianna; Botto-van Bemden, Angie; Sciortino Contreras, Rosa Maya; Scotton, Deborah; Bibas, Marco; Quintero, Maritza; Monfort, Jordi; Carné, Xavier; de Abajo, Francisco; Oswald, Elizabeth; Cabot, Maria R; Matucci, Marco; du Souich, Patrick; Möller, Ingrid; Eakin, Guy; Verges, Josep
关节炎
发表日期：2019
文献求助 收藏

Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative group

法布里病酶替代疗法居家输液项目：意大利大型合作组的经验

期刊:Molecular Genetics and Metabolism Reports
影响因子:1.9
doi:10.1016/j.ymgmr.2017.06.005
Concolino, D; Amico, L; Cappellini, M D; Cassinerio, E; Conti, M; Donati, M A; Falvo, F; Fiumara, A; Maccarone, M; Manna, R; Matucci, A; Musumeci, M B; Nicoletti, A; Nisticò, R; Papadia, F; Parini, R; Peluso, D; Pensabene, L; Pisani, A; Pistone, G; Rigoldi, M; Romani, I; Tenuta, M; Torti, G; Veroux, M; Zachara, E
发表日期：2017
文献求助 收藏

The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis

美国风湿病学会早期弥漫性皮肤系统性硬化症临床试验临时综合反应指数

期刊:Arthritis & Rheumatology
影响因子:10.9
doi:10.1002/art.39501
Khanna, Dinesh; Berrocal, Veronica J; Giannini, Edward H; Seibold, James R; Merkel, Peter A; Mayes, Maureen D; Baron, Murray; Clements, Philip J; Steen, Virginia; Assassi, Shervin; Schiopu, Elena; Phillips, Kristine; Simms, Robert W; Allanore, Yannick; Denton, Christopher P; Distler, Oliver; Johnson, Sindhu R; Matucci-Cerinic, Marco; Pope, Janet E; Proudman, Susanna M; Siegel, Jeffrey; Wong, Weng Kee; Wells, Athol U; Furst, Daniel E
免疫/内分泌
系统性硬化症
发表日期：2016
文献求助 收藏

Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?

罕见肺部疾病和孤儿药：我们目前处于什么阶段，未来将走向何方？

期刊:European Respiratory Review
影响因子:10.4
doi:10.1183/16000617.0051-2015
Harari, Sergio; Humbert, Marc; Blasi, Francesco; Collard, Harold R; Matucci-Cerinic, Marco; Simonneau, Gerald; Vancheri, Carlo; Wells, Athol U; Cottin, Vincent
发表日期：2015
文献求助 收藏

Safety and effectiveness of adalimumab in patients with rheumatoid arthritis over 5 years of therapy in a phase 3b and subsequent postmarketing observational study

在一项 3b 期临床试验和后续上市后观察性研究中，评估了阿达木单抗治疗类风湿性关节炎患者 5 年的安全性和有效性

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/ar4452
Burmester, Gerd R; Matucci-Cerinic, Marco; Mariette, Xavier; Navarro-Blasco, Francisco; Kary, Sonja; Unnebrink, Kristina; Kupper, Hartmut
关节炎
发表日期：2014
文献求助 收藏

The new low-toxic histone deacetylase inhibitor S-(2) induces apoptosis in various acute myeloid leukaemia cells

新型低毒组蛋白去乙酰化酶抑制剂S-(2)诱导多种急性髓系白血病细胞凋亡

期刊:Journal of Cellular and Molecular Medicine
影响因子:4.3
doi:10.1111/j.1582-4934.2011.01464.x
C Cellai, M Balliu, A Laurenzana, L Guandalini, R Matucci, D Miniati, E Torre, A Nebbioso, V Carafa, L Altucci, M N Romanelli, F Paoletti
免疫
细胞生物学
白血病
肿瘤细胞
Apoptosis
发表日期：2012
文献求助 收藏

Development of a provisional core set of response measures for clinical trials of systemic sclerosis

制定系统性硬化症临床试验的临时核心反应指标集

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/ard.2007.078923
Khanna, D; Lovell, D J; Giannini, E; Clements, P J; Merkel, P A; Seibold, J R; Matucci-Cerinic, M; Denton, C P; Mayes, M D; Steen, V D; Varga, J; Furst, D E
系统性硬化症
免疫/内分泌
发表日期：2008
文献求助 收藏